-
Concanavalin A and Conserved Coronavirus Glycans
2026-09-16
Guo et al. identify conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a vulnerability that can be targeted by concanavalin A. Using fusion, pseudovirus, authentic-virus, biochemical, and mouse infection models, the study links lectin binding to impaired spike activation and broad antiviral activity.
-
FTH-Driven Ferroptosis in TP53-Mutant Glioblastoma
2026-09-16
The reference study identifies an iron-homeostasis mechanism in which TP53 gain-of-function activity increases ITCH, promotes FTH degradation, and expands the labile iron pool in glioblastoma models. This state does not simply increase iron tolerance: it also creates greater vulnerability to Erastin-induced ferroptosis, particularly when combined with ferric ammonium citrate.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Lab Guide
2026-09-15
This scenario-based guide shows how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, can separate delivery, uptake, and translation variables in viability, proliferation, and cytotoxicity workflows. It combines practical protocol guidance with evidence-linked interpretation for dual fluorescence and bioluminescence readouts.
-
SPEN Binding Rules in XIST A-Repeat RNA
2026-09-15
Button et al. define how the SPEN RNA recognition motif and the multimeric architecture of the XIST A-repeat region cooperate to produce high-affinity binding in vitro. Their combination of domain dissection, RNA construct analysis, chemical structure probing, and computational modeling identifies a sequence–structure motif relevant to the initiation of X-chromosome inactivation.
-
ATRA Reverses Cisplatin-Linked PARP Resistance
2026-09-14
The reference study identifies all-trans retinoic acid (ATRA) as a sequence-aware strategy for reducing cisplatin-associated resistance to PARP inhibition in epithelial ovarian cancer. Its findings connect ATRA activity to suppression of a PARP inhibitor-resistant state marked by altered NAD+ metabolism, ALDH1A1, NAMPT, PARP1, and checkpoint kinase 1, with improved responses to niraparib maintenance in preclinical models.
-
EZ Cap™ Cas9 mRNA (m1Ψ): A Design-to-Assay Guide
2026-09-14
EZ Cap™ Cas9 mRNA (m1Ψ) combines Cap1 capping, m1Ψ modification, and a poly(A) tail for transient CRISPR-Cas9 genome editing. This article provides an assay-centered framework for interpreting mRNA trafficking, innate immune sensing, and editing specificity rather than simply describing product architecture.
-
Chloroquine Research Workflows and Optimization
2026-09-13
Build more reproducible autophagy, lysosomal, Toll-like receptor, cancer, malaria, and rheumatoid arthritis assays with a defined Chloroquine workflow. This guide combines concentration planning, pharmacogenomic context, cross-domain use cases, and practical troubleshooting for research teams.
-
Influenza Hemagglutinin (HA) Peptide: Lab Guide
2026-09-12
A scenario-based guide to using Influenza Hemagglutinin (HA) Peptide, SKU A6004, to connect cell viability or cytotoxicity phenotypes with HA-tagged protein detection and purification. It covers competitive antibody elution, solvent and storage controls, interpretation limits, and practical vendor-selection criteria.
-
Cy3 Goat Anti-Human IgG: Assay Decision Guide
2026-09-11
The Cy3 Goat Anti-Human IgG (H+L) Antibody supports sensitive human IgG detection across fluorescence, tissue, flow, and ELISA workflows. This evidence-based guide explains how to select controls, interpret signal, and connect antibody discovery findings to defensible assay design.
-
Proteinase K for DNA Isolation Workflows
2026-09-11
Proteinase K combines broad-spectrum protein digestion with compatibility across SDS, EDTA, and moderate-to-elevated temperatures, making it useful for genomic DNA isolation and contaminant removal. This practical guide explains workflow design, assay controls, troubleshooting, and how findings from a SARS-CoV-2 protease study inform selectivity testing without confusing a cleanup enzyme with an antiviral target.
-
Triiodothyronine (T3): Mechanism and Research Use
2026-09-10
Triiodothyronine (T3) is the biologically active thyroid hormone that regulates transcription through nuclear thyroid hormone receptors. This article connects T3 reagent specifications with thyroid hormone signaling pathway research, adipose thermogenesis, and reproducible cellular metabolism assay design.
-
ARCA Cy5 EGFP mRNA: Tracking & Translation
2026-09-10
ARCA Cy5 EGFP mRNA (5-moUTP) combines covalent Cy5 labeling, EGFP expression, an ARCA cap, and 5-methoxyuridine modified mRNA chemistry for direct studies of RNA delivery and translation. Product-defined specifications include a 996-nucleotide length, 1 mg/mL concentration, and storage at −40 °C or below.
-
Halazone Workflows for Water and Nerve Assays
2026-09-09
Halazone connects rapid oxidative water disinfection with a distinctive voltage-clamp assay for sodium-current inactivation. This guide translates those findings into practical preparation, exposure, control, troubleshooting, and cross-domain interpretation strategies.
-
Cisapride in Cardiotoxicity Screening Workflows
2026-09-09
Cisapride, also known as R 51619, connects 5-HT4 receptor pharmacology with hERG-focused cardiac safety testing. This guide translates its dual activity into practical iPSC-cardiomyocyte, high-content imaging, and electrophysiology workflows, with formulation and assay troubleshooting built in.
-
Filipin III for Membrane Cholesterol Workflows
2026-09-08
Filipin III connects cholesterol-sensitive fluorescence with membrane imaging, vesicle assays, and ultrastructural analysis. This practical guide shows how to build reproducible workflows, interpret fluorescence changes cautiously, and apply the probe to macrophage lipid dysregulation research.